Literature DB >> 18507002

DNA damage response in prostate cancer cells after high-intensity focused ultrasound (HIFU) treatment.

Hisamitsu Ide1, Takashi Nakagawa, Yuichi Terado, Mitsuko Yasuda, Yutaka Kamiyama, Satoru Muto, Shigeo Horie.   

Abstract

BACKGROUND: High-intensity focused ultrasound (HIFU) is a new modality that can be used for local tumor ablation therapy. In the present study, the expression of human checkpoint kinase2 (Chk2), which may have significant roles in the response to DNA damage after HIFU treatment for prostate cancer, was examined.
MATERIALS AND METHODS: By immunohistochemistry, the Chk2 expression in human prostate cancer tissues was examined before and after HIFU treatment. The phosphorylation of ataxia-telangiectasia-mutated kinase (ATM), histone H2A variant (H2AX), Chk2 and p53, and the number of apoptotic cells in human prostate cancer cell lines after heat treatment was checked.
RESULTS: The expression level of phosphorylated Chk2 was found to be increased after HIFU treatment. In addition, heat treatment induced the phosphorylation of Chk2 proteins examined and led to apoptosis in the prostate cancer cells.
CONCLUSION: Our results suggest that DNA double-strand break formation is a possible pathway of HIFU treatment and leads to heat-induced cell killing.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18507002

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  5 in total

1.  Utility of immunohistochemistry markers in the interpretation of post-high-intensive focussed ultrasound prostate biopsy cores.

Authors:  B Walter; T Weiss; F Hofstädter; A Gaumann; A Hartmann; S Rogenhofer; R Ganzer; S Wach; D Engehausen; W F Wieland; A Blana
Journal:  World J Urol       Date:  2012-02-19       Impact factor: 4.226

2.  Ultrasound-induced new cellular mechanism involved in drug resistance.

Authors:  Mariame A Hassan; Yukihiro Furusawa; Masami Minemura; Natalya Rapoport; Toshiro Sugiyama; Takashi Kondo
Journal:  PLoS One       Date:  2012-12-19       Impact factor: 3.240

Review 3.  Epigenetic Editing in Prostate Cancer: Challenges and Opportunities.

Authors:  Mariana Brütt Pacheco; Vânia Camilo; Rui Henrique; Carmen Jerónimo
Journal:  Epigenetics       Date:  2021-06-15       Impact factor: 4.861

Review 4.  A review on the use of magnetic fields and ultrasound for non-invasive cancer treatment.

Authors:  Somoshree Sengupta; Vamsi K Balla
Journal:  J Adv Res       Date:  2018-06-20       Impact factor: 10.479

Review 5.  Epigenetic regulation of prostate cancer: the theories and the clinical implications.

Authors:  Yiji Liao; Kexin Xu
Journal:  Asian J Androl       Date:  2019 May-Jun       Impact factor: 3.285

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.